#USA #Philadelphia #IntegriChain #Pharma Strategies #GTN Insights

IntegriChain Leaders to Speak at Major Fall Conferences

IntegriChain, recognized as a frontrunner in optimizing pharmaceutical net revenue through advanced technology, data, and consulting, has announced its participation in three high-profile industry events this fall. The company will provide valuable insights into several pressing topics at the Medicaid Drug Rebate Program (MDRP) Summit, the Pharma/Biotech Gross-to-Net (GTN) Summit, and Trade Channel Strategies.

Insights into Evolving Pricing and Contracting

As the pharmaceutical landscape continues to shift, government pricing and contracting issues are becoming increasingly intertwined. Jeff Baab, a partner in Advisory Services at IntegriChain, will present at the MDRP Summit from October 5 to 7, 2026, held at the Fairmont Chicago Millennium Park. Baab’s session titled "Updates on the Landscape of Government Pricing and Contracting" will take place on October 7 at 9:40 AM, and he aims to equip attendees with actionable insights derived from his extensive experience with manufacturers across various sectors.

Joining him is Clay Willis, another partner at IntegriChain, who will discuss the "340B Movement to Have All 340B Claims in One System of Record" at 10:50 AM on the same day. This session will cover recent developments in the 340B program and their implications for pharmaceutical pricing strategies.

Addressing Gross-to-Net Challenges

Moving forward to the Pharma/Biotech GTN Summit from November 16 to 18, 2026, in Philadelphia, two of IntegriChain's leaders will take the stage to address key challenges in gross-to-net strategy. Jennifer Sharpe, Vice President of Gross-to-Net Consulting, will facilitate a Hot Topic Roundtable Discussions on November 16 at 4:30 PM, bringing together over 800 members of the Revenue Analytics Collaborative to discuss current issues affecting GTN strategies.

On November 17 at 10:55 AM, Walt Worsham, Managing Director at IntegriChain, will deliver a critical presentation titled "Drug Pricing Policy Regulatory Landscape Updates," focusing on recent policy changes impacting forecasting and contracting strategies in the pharmaceutical industry.

Future of Pharmaceutical Distribution

The Trade Channel Strategies 2026 event, scheduled for December 8-10, 2026, at the W Hotel, Philadelphia, will feature a keynote address by Bill Roth, Senior Vice President and Managing Partner of Consulting and Advisory at IntegriChain. Roth will discuss the complexities facing today’s pharmaceutical distribution systems, highlighting the challenges and opportunities resulting from reimbursement pressures at national retailers and their downstream effects on specialty drugs and general medicine brands.

These events provide an invaluable platform for IntegriChain's leaders to share real-world insights gathered from their extensive clientele of manufacturers. Baab notes, “The interconnectedness of government pricing, 340B, gross-to-net forecasting, and trade and channel strategies has never been more significant for our clients.”

Attendees can anticipate engaging sessions that promise to deepen their understanding of these topics and equip them with strategies to navigate an evolving contracting landscape effectively.

IntegriChain strives to ensure that biopharma companies optimize patient access to therapies while maximizing net revenue performance. For more information on their initiatives and expert insights, visit www.integrichain.com or connect with them on LinkedIn.

About IntegriChain

IntegriChain provides unique data-driven solutions for biopharma, linking commercial, financial, and operational aspects of drug access and profitability. Their innovative ICyte® platform is designed to streamline workflows and improve analytics, enabling pharmaceutical companies to enhance compliance and reach patients more effectively. Headquartered in Philadelphia, PA, IntegriChain also has a facility in Pune, India, and is backed by Nordic Capital, a specialist investor in healthcare and technology sectors. For further details, visit www.integrichain.com.